You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

CLINICAL TRIALS PROFILE FOR DEMADEX

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DEMADEX

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00602303 ↗	Bioequivalency Study of Torsemide Tablets Under Fasting Conditions	Completed	Roxane Laboratories	N/A	2003-09-01	The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fasting conditions using a single-dose, 2-treatment, 2-period, crossover design.
NCT00602615 ↗	Bioequivalency Study of Torsemide Tablets Under Fed Conditions	Completed	Roxane Laboratories	N/A	2003-09-01	The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fed conditions using a single-dose, 2-treatment, 2-period, crossover design.
NCT00653549 ↗	Bioavailability Study of Torsemide Tablets Under Fasting Conditions	Completed	Anapharm	Phase 1	2001-04-01	To compare the single-dose bioavailability of Torsemide tablets with Demadex
NCT00653549 ↗	Bioavailability Study of Torsemide Tablets Under Fasting Conditions	Completed	Par Pharmaceutical, Inc.	Phase 1	2001-04-01	To compare the single-dose bioavailability of Torsemide tablets with Demadex
NCT00654043 ↗	Bioavailability Study of Torsemide Tablets Under Fed Conditions	Completed	Anapharm	Phase 1	2001-04-01	To compare the single-dose bioavailability of Torsemide tablets with Demadex
NCT00654043 ↗	Bioavailability Study of Torsemide Tablets Under Fed Conditions	Completed	Par Pharmaceutical, Inc.	Phase 1	2001-04-01	To compare the single-dose bioavailability of Torsemide tablets with Demadex
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DEMADEX

Condition Name

Chart
Table

Condition Name for DEMADEX
Intervention	Trials
Edema	2
Body Weight Changes	1
Chronic Kidney Diseases	1
Congestive Heart Failure	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DEMADEX
Intervention	Trials
Malnutrition	2
Heart Failure	2
Disease	1
Body Weight Changes	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DEMADEX

Trials by Country

Map
Table

Trials by Country for DEMADEX
Location	Trials
United States	3
India	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DEMADEX
Location	Trials
Missouri	2
New York	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DEMADEX

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DEMADEX
Clinical Trial Phase	Trials
Phase 4	1
Phase 1	4
N/A	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DEMADEX
Clinical Trial Phase	Trials
Completed	5
Recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DEMADEX

Sponsor Name

Chart
Table

Sponsor Name for DEMADEX
Sponsor	Trials
Roxane Laboratories	2
Anapharm	2
Par Pharmaceutical, Inc.	2
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DEMADEX
Sponsor	Trials
Industry	8
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.